Ichiro M. Omori

发表

Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis

J. Geddes, M. Tansella, J. Higgins, 2009, The Lancet.

Efficacy and Tolerability of Milnacipran in the Treatment of Major Depression in Comparison with Other Antidepressants

T. Furukawa, N. Watanabe, A. Cipriani, 2008, CNS drugs.

Mirtazapine versus other antidepressive agents for depression.

Rachel Churchill, Andrea Cipriani, Toshi A Furukawa, 2010, The Cochrane database of systematic reviews.

Association between unreported outcomes and effect size estimates in Cochrane meta-analyses.

G. Guyatt, T. Furukawa, V. Montori, 2007, JAMA.

Psychotherapy for depression among children and adolescents: a systematic review

T. Furukawa, N. Watanabe, R. Churchill, 2007, Acta psychiatrica Scandinavica.

Supported employment for adults with severe mental illness.

T. Furukawa, N. Watanabe, I. M. Omori, 2013, The Cochrane database of systematic reviews.

Supported employment for adults with severe mental illness.

T. Furukawa, I. M. Omori, G. Bond, 2013, The Cochrane database of systematic reviews.

Mirtazapine versus other antidepressants in the acute-phase treatment of adults with major depression: systematic review and meta-analysis.

N. Watanabe, A. Cipriani, C. Barbui, 2008, The Journal of clinical psychiatry.

Elucidation of the relationship between sensory processing and white matter using diffusion tensor imaging tractography in young adults

H. Okazawa, H. Kosaka, I. M. Omori, 2021, Scientific Reports.

Fluvoxamine versus other anti-depressive agents for depression.

T. Furukawa, N. Watanabe, A. Cipriani, 2010, The Cochrane database of systematic reviews.

Can pill placebo augment cognitive-behavior therapy for panic disorder?

T. Furukawa, N. Watanabe, R. Churchill, 2007, BMC psychiatry.

Changes after behavior therapy among responsive and nonresponsive patients with obsessive-compulsive disorder

S. Nakaaki, T. Furukawa, T. Iidaka, 2009, Psychiatry Research: Neuroimaging.

Distinct neuropsychological profiles of three major symptom dimensions in obsessive–compulsive disorder

M. Mimura, S. Nakaaki, Junko Sato, 2011, Psychiatry Research.

The differential impact of executive attention dysfunction on episodic memory in obsessive-compulsive disorder patients with checking symptoms vs. those with washing symptoms.

S. Nakaaki, T. Furukawa, I. M. Omori, 2007, Journal of psychiatric research.

Duloxetine versus other anti-depressive agents for depression.

T. Furukawa, A. Cipriani, C. Barbui, 2012, Cochrane Database of Systematic Reviews.

Sulpiride versus other antipsychotics for schizophrenia

Jijun Wang, I. M. Omori, B. Soares, 2009 .

Milnacipran versus other antidepressive agents for depression.

T. Furukawa, N. Watanabe, A. Cipriani, 2009, The Cochrane database of systematic reviews.

Venlafaxine versus other anti-depressive agents for depression.

T. Furukawa, A. Cipriani, C. Barbui, 2007, The Cochrane database of systematic reviews.

Safety Reporting and Adverse-Event Profile of Mirtazapine Described in Randomized Controlled Trials in Comparison with Other Classes of Antidepressants in the Acute-Phase Treatment of Adults with Depression

T. Furukawa, N. Watanabe, A. Cipriani, 2010, CNS Drugs.

Sulpiride augmentation for schizophrenia.

Jijun Wang, I. M. Omori, B. Soares, 2010, The Cochrane database of systematic reviews.

Fluvoxamine versus other anti-depressive agents for depression.

T. Furukawa, N. Watanabe, A. Cipriani, 2010, The Cochrane database of systematic reviews.

Sulpiride versus placebo for schizophrenia.

Jijun Wang, Ichiro M. Omori, 2009, The Cochrane database of systematic reviews.

Guided internet-based cognitive behavioral therapy for obsessive-compulsive disorder: A multicenter randomized controlled trial in Japan

C. Sutoh, H. Kosaka, I. M. Omori, 2022, Internet interventions.

Milnacipran versus other antidepressive agents for depression.

T. Furukawa, N. Watanabe, A. Cipriani, 2007, The Cochrane database of systematic reviews.

Relationship between sensory characteristics and cortical thickness/volume in autism spectrum disorders

H. Okazawa, H. Kosaka, I. M. Omori, 2021, Translational Psychiatry.

Making the best use of available evidence: the case of new generation antidepressants

J. Geddes, J. Higgins, N. Watanabe, 2009, Evidence-based mental health.

T. Furukawa, N. Watanabe, A. Cipriani, 2010, CNS drugs.

Duloxetine versus other anti-depressive agents for depression.

T. Furukawa, A. Cipriani, C. Barbui, 2012, The Cochrane database of systematic reviews.